Invesco S&P 500 Equal Weight Health Care ETF (RSPH)
| Assets | $900.01M |
| Expense Ratio | 0.40% |
| PE Ratio | 24.91 |
| Shares Out | 29.24M |
| Dividend (ttm) | $0.20 |
| Dividend Yield | 0.66% |
| Ex-Dividend Date | Sep 23, 2024 |
| Payout Ratio | 16.40% |
| 1-Year Return | +20.20% |
| Volume | 46,540 |
| Open | 30.64 |
| Previous Close | 30.81 |
| Day's Range | 30.41 - 30.65 |
| 52-Week Low | 25.54 |
| 52-Week High | 32.85 |
| Beta | 0.85 |
| Holdings | 63 |
| Inception Date | Nov 1, 2006 |
About RSPH
Fund Home PageThe Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equal-weighted index of US health care companies taken from the S&P 500 Index. RSPH was launched on Nov 1, 2006 and is issued by Invesco.
Top 10 Holdings
17.55% of assets| Name | Symbol | Weight |
|---|---|---|
| Gilead Sciences, Inc. | GILD | 1.81% |
| Bristol-Myers Squibb Company | BMY | 1.81% |
| Solventum Corporation | SOLV | 1.77% |
| Intuitive Surgical, Inc. | ISRG | 1.76% |
| DexCom, Inc. | DXCM | 1.75% |
| Incyte Corporation | INCY | 1.74% |
| West Pharmaceutical Services, Inc. | WST | 1.74% |
| Labcorp Holdings Inc. | LH | 1.74% |
| Becton, Dickinson and Company | BDX | 1.72% |
| Boston Scientific Corporation | BSX | 1.72% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 23, 2024 | $0.05474 | Sep 27, 2024 |
| Jun 24, 2024 | $0.05076 | Jun 28, 2024 |
| Mar 18, 2024 | $0.04585 | Mar 22, 2024 |
| Dec 18, 2023 | $0.04988 | Dec 22, 2023 |
| Sep 18, 2023 | $0.04794 | Sep 22, 2023 |
| Jun 20, 2023 | $0.0511 | Jun 23, 2023 |
News
RSPH: Outperformance In 2025 Expected
Invesco S&P 500 Equal Weight Health Care ETF's equal-weight strategy should outperform in a lower rate environment, despite its higher expense ratio compared to market-cap weighted ETFs. The healthcar...
RSPH: Healthcare Dashboard For May 2024
This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores...
RSPH: The Time For Healthcare And Equal Weight Will Come
Healthcare may benefit from a reallocation away from large-cap Technology as investors seek better value. Invesco S&P 500® Equal Weight Health Care ETF provides diversified exposure to the healthcare ...
RSPH: Balanced Outlook, Look For Selective Opportunities Over Broad Holdings
Various stages of the market + business cycle call for rotational strategies in tactical allocation. Healthcare emerges as one standout in defensive markets and is worth a thoughtful analysis. Q3 earn...